Previous 10 | Next 10 |
Pacira BioSciences, Inc. (PCRX) Q2 2021 Earnings Conference Call August 3, 2021 08:30 AM ET Company Participants Susan Mesco - IR Dave Stack - Chairman and CEO Charlie Reinhart - CFO Roy Winston - Interim Chief Medical Officer Conference Call Participants Daniel Busby - RBC Capital Markets Da...
Image source: The Motley Fool. Pacira BioSciences, inc (NASDAQ: PCRX) Q2 2021 Earnings Call Aug 3, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Pacira BioSciences, inc (PCRX) Q2 2021 Earnings Call Transcript
Pacira BioSciences (NASDAQ:PCRX) announces that the U.S. FDA has approved the company’s enhanced manufacturing process for EXPAREL. EXPAREL is housed at a custom facility in Swindon, England under a partnership with Thermo Fisher Scientific Pharma Services. The com...
-- New 200-liter suite doubles capacity to meet growing EXPAREL demand -- -- Patent covering enhanced manufacturing process extends proprietary position to January 2041 -- PARSIPPANY, N.J., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the indu...
PARSIPPANY, N.J., July 29, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced new data on the ability of the iovera°® system to reduce pain, opioid consumption, and length of stay (LOS) following total knee arthroplasty (TKA). The findings sho...
naphtalina/iStock via Getty Images JP Morgan analysts view Pacira BioSciences (PCRX) as an “attractive valuation case,” noting that the shares of the Exparel maker have slumped more than a quarter from the peak in 2021. Christopher Neyor and the team have raised their recommenda...
PARSIPPANY, N.J., July 20, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on Tuesday, August 3, 2021. Following the release, the company will host a live conference ...
Urupong/iStock via Getty Images Pacira BioSciences ([[PCRX]] -2.1%) reported record net revenue of $135.6M in Q2 2021. Product sales of Exparel (bupivacaine liposome injectable suspension) and iovera, a cryoanalgesia device, which were, respectively, $130.1M and $3.8M, in the quarter. Pa...
-- EXPAREL average daily sales at 178% of the prior year for the second quarter and 120% of the prior year for the month of June -- PARSIPPANY, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain manag...
janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...